Singapore: Taiwan's PAREXEL International, a biopharmaceutical services provider, and National Taiwan University Hospita...
According to business intelligence provider, GBI Research, total number of deals in the global contract research organiz...
Mr Malcolm Burgess relocated to Hong Kong in 2011 to take up the role of executive vice president of ICON with special r...
Malaysia's aspiration is to be a developed nation by the year 2020. With 10 years more to prepare for this anticipated...
Singapore: Pharmaceutical Product Development, (PPD) has acquired Acurian, a service provider of clinical trial patient ...
Singapore: Daiichi Sankyo is expanding its use of US-based Medidata Solutions' cloud-based platform to support clinical ...
Demand in emerging markets is opening up newer opportunities across various sectors and life sciences companies have sev...
China's growing economic strength and population of 1.3 billion people holds tremendous potential for global pharma and ...
Singapore: Australian company Linear Clinical Research has won the Emerging Exporter of the year Award at the 50th annua...
New Delhi: At a media workshop on the clinical research industry (CRO) held at Delhi on July 13, 2012, industry experts ...
Singapore: Senz Oncology announced that the ï¬rst patient has commenced treatment in a phase I/II clinical evaluati...
Everything does not seem to be well in the pharmaceutical industry of Asia's third largest economy - India. Although the...
Singapore: Resverlogix has initiated an exploratory phase II clinical trial in patients with pre-diabetes mellitus to e...
Singapore: Global clinical supply chain solutions provider Marken has been granted a 12-year license to ship biological ...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
The clinical trials landscape in Malaysia is very easy to navigate. The Malaysian government has been actively promoti...
‎Singapore: ReSearch Pharmaceutical Services, a clinical research firm, has appointed Mr Marc Wolff as its chief f...
Singapore: Patrys, a clinical stage biotechnology company, has received approval to progress its Phase I/IIa PAT-SM6 mul...
